Literature DB >> 7539751

Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand.

G A Bishop1, W D Warren, M T Berton.   

Abstract

Activated T cells induce proliferation and differentiation of resting B cells in vitro through their CD40 molecules and lymphokine receptors. However, despite constitutive B cell expression of CD40 and lymphokine receptors, widespread nonspecific polyclonal B cell activation by activated T cells is seldom observed in vivo. The present study was designed to test the hypothesis that signals delivered via the B cell antigen (Ag) receptor (membrane immunoglobulin, mIg) and major histocompatibility complex (MHC) class II molecules enhance B cell responsiveness to CD40-mediated signals, providing specificity to the Ag-nonspecific, MHC-unrestricted CD40 signal. To test this hypothesis, both an Ag-specific mouse B cell clone CH12.LX, and freshly isolated resting splenic B cells were cultured with either soluble or membrane-bound forms of the T cell ligand for CD40 (CD40L), in the presence or absence of additional signals provided by Ag or anti-IgM, interleukin-4, and class II-specific monoclonal antibody (mAb). Differentiation of CH12.LX cells and proliferation of splenic B cells in response to both forms of CD40L was greatly enhanced by exposure to mIg-mediated signals, with greatest enhancement seen when cells were cultured with Ag prior to receiving other signals. Response to CD40L was further enhanced by concurrent culture with class II-specific, but not class I-specific mAb. Enhancement was greatest at limiting concentrations of CD40L. The ability of class II MHC-mediated signals to enhance Ag-specific B cell responsiveness to CD40-mediated signaling may selectively promote the activation of B cell clones capable of cognate interactions with helper T cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539751     DOI: 10.1002/eji.1830250515

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).

Authors:  K D Brown; B S Hostager; G A Bishop
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

2.  Enhancement of antibody class-switch recombination by the cumulative activity of four separate elements.

Authors:  Wesley A Dunnick; Jian Shi; Jennifer M Zerbato; Clinton A Fontaine; John T Collins
Journal:  J Immunol       Date:  2011-09-26       Impact factor: 5.422

3.  Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma.

Authors:  Melissa E Munroe; Thomas R Businga; Joel N Kline; Gail A Bishop
Journal:  J Immunol       Date:  2010-10-01       Impact factor: 5.422

4.  Macrophages prevent the differentiation of autoreactive B cells by secreting CD40 ligand and interleukin-6.

Authors:  Michelle A Kilmon; Nikki J Wagner; Alaina L Garland; Li Lin; Katja Aviszus; Lawrence J Wysocki; Barbara J Vilen
Journal:  Blood       Date:  2007-09-01       Impact factor: 22.113

5.  Frontline Science: CD40 signaling restricts RNA virus replication in Mϕs, leading to rapid innate immune control of acute virus infection.

Authors:  Kai J Rogers; Olena Shtanko; Laura L Stunz; Laura N Mallinger; Tina Arkee; Megan E Schmidt; Dana Bohan; Bethany Brunton; Judith M White; Steve M Varga; Noah S Butler; Gail A Bishop; Wendy Maury
Journal:  J Leukoc Biol       Date:  2020-05-22       Impact factor: 4.962

Review 6.  Signaling by CD40 and its mimics in B cell activation.

Authors:  G A Bishop; B S Hostager
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

7.  Composite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survival.

Authors:  Jakrawadee Julamanee; Seitaro Terakura; Koji Umemura; Yoshitaka Adachi; Kotaro Miyao; Shingo Okuno; Erina Takagi; Toshiyasu Sakai; Daisuke Koyama; Tatsunori Goto; Ryo Hanajiri; Michael Hudecek; Peter Steinberger; Judith Leitner; Tetsuya Nishida; Makoto Murata; Hitoshi Kiyoi
Journal:  Mol Ther       Date:  2021-05-01       Impact factor: 12.910

8.  Transgenes of the mouse immunoglobulin heavy chain locus, lacking distal elements in the 3' regulatory region, are impaired for class switch recombination.

Authors:  Wesley A Dunnick; Jian Shi; Clinton Fontaine; John T Collins
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

9.  Roles of the kinase TAK1 in TRAF6-dependent signaling by CD40 and its oncogenic viral mimic, LMP1.

Authors:  Kelly M Arcipowski; Gail A Bishop
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

Review 10.  The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity.

Authors:  Yuan He; Martijn Vlaming; Tom van Meerten; Edwin Bremer
Journal:  Cancers (Basel)       Date:  2022-01-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.